|
Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors
RECRUITINGN/ASponsored by HealthNet Transcultural Psychosocial Organization
Actively Recruiting
PhaseN/A
SponsorHealthNet Transcultural Psychosocial Organization
Started2024-12-24
Est. completion2026-11-30
Eligibility
Age20 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07350694
Summary
This project aims to adapt, implement, and evaluate PLA based intervention in Rural Kabul, Afghanistan for TIIDM prevention and control.
Eligibility
Age: 20 Years+Healthy volunteers accepted
Inclusion Criteria: * For intervention phase: Individuals aged 20 years and above. For baseline and endline assessments (before and after the intervention): Individuals aged 30 years and above. * Participants residing in the randomized clusters of Kabul, Afghanistan Individuals willing to participate in the study and provide consent. * All individuals with normoglycemia, intermediate hyperglycaemia, and diabetes are encouraged to participate. * Participants who can attend the scheduled meetings and interventions as per the study protocol. Exclusion Criteria: * For Intervention phase: Individuals below the age of 20 years. For baseline and endline assessments (before and after the intervention): individuals below the age of 30 years. * Individuals unwilling to provide consent for participation. * Participants with reported health conditions that may hinder their active involvement in the study. * Individuals with non-compliance with research protocols
Conditions3
DiabetesDiabetes Type 2Type II Diabetes Mellitus
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorHealthNet Transcultural Psychosocial Organization
Started2024-12-24
Est. completion2026-11-30
Eligibility
Age20 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07350694